Immuneering Corp Cl A
(IMRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -61,037 | -53,472 | -50,514 | -33,536 | -17,040 |
| Depreciation Amortization | 454 | -253 | 625 | 289 | 79 |
| Income taxes - deferred | N/A | N/A | N/A | -308 | N/A |
| Accounts receivable | 0 | 12 | 234 | 280 | -290 |
| Accounts payable and accrued liabilities | -112 | -1,107 | 1,760 | -130 | 1,186 |
| Other Working Capital | -925 | -975 | 1,717 | 900 | 1,253 |
| Other Operating Activity | 6,620 | 6,826 | 2,076 | 1,653 | 191 |
| Operating Cash Flow | $-55,000 | $-48,969 | $-44,101 | $-30,851 | $-14,621 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 31,930 | 52,300 | 92,678 | N/A | N/A |
| PPE Investments | -85 | -343 | -743 | -61 | -53 |
| Purchase Of Investment | -5,410 | -44,661 | -50,105 | -75,626 | 0 |
| Other Investing Activity | 0 | 0 | 0 | 70 | 0 |
| Investing Cash Flow | $26,435 | $7,297 | $41,831 | $-75,616 | $-53 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 5,345 | 28,645 | 300 | 121,600 | 0 |
| Other Financing Activity | -41 | -204 | -281 | 22,665 | 37,982 |
| Financing Cash Flow | $5,304 | $28,441 | $19 | $144,265 | $37,982 |
| Beginning Cash Position | 59,406 | 72,637 | 74,888 | 37,090 | 13,782 |
| End Cash Position | 36,145 | 59,406 | 72,637 | 74,888 | 37,090 |
| Net Cash Flow | $-23,261 | $-13,231 | $-2,251 | $37,798 | $23,308 |
| Free Cash Flow | |||||
| Operating Cash Flow | -55,000 | -48,969 | -44,101 | -30,851 | -14,621 |
| Capital Expenditure | -85 | -343 | -743 | -61 | -53 |
| Free Cash Flow | -55,085 | -49,311 | -44,844 | -30,912 | -14,674 |